【摘要】 肿瘤微创治疗越来越受到临床医生和患者的重视。近年来,影像引导下的肿瘤物理、化学消融治疗和125I粒子植入组织间近距离放疗已经成为治疗肿瘤的首选方法之一。磁共振成像(magnetic resonance imaging,MRI)具有CT、超声、数字减影血管造影机(digital subtraction angiography,DSA)无法比拟的优越性,尤其对于颅内肿瘤的诊断及介入微创治疗更显示出其独特优势。然而,MRI也具有伪影、消融范围、手术操作复杂等不足。本文旨在浅析颅内胶质瘤和转移瘤在MRI引导下微创治疗的优劣及对策。更多还原

【Abstract】 Minimally invasive treatment has received increasing attention in the field of tumor therapy. Imaging-guided ablation(physical or chemical) and125 I particle implantation have recently become first-line therapies for malignant tumors. A comparison with computed tomography, ultrasound, or digital subtraction angiography(DSA) illustrates that magnetic resonance imaging(MRI) shows extreme superiority in both intracranial tumor diagnosis and interventional therapy. Nevertheless, MRI also has a deficiency. This study aims to discuss the value of an MRI-guided minimally invasive treatment in glioma and its metastatic tumor.更多还原